Your browser doesn't support javascript.
loading
Second primary malignancies in multiple myeloma: an overview and IMWG consensus.
Musto, P; Anderson, K C; Attal, M; Richardson, P G; Badros, A; Hou, J; Comenzo, R; Du, J; Durie, B G M; San Miguel, J; Einsele, H; Chen, W M; Garderet, L; Pietrantuono, G; Hillengass, J; Kyle, R A; Moreau, P; Lahuerta, J J; Landgren, O; Ludwig, H; Larocca, A; Mahindra, A; Cavo, M; Mazumder, A; McCarthy, P L; Nouel, A; Rajkumar, S V; Reiman, A; Riva, E; Sezer, O; Terpos, E; Turesson, I; Usmani, S; Weiss, B M; Palumbo, A.
Afiliação
  • Musto P; Scientific Direction, IRCCS-CROB, Referral Cancer Center of Basilicata, Rionero in Vulture, Italy.
  • Anderson KC; Hematologic Oncology, Dana-Farber Cancer Institute, Boston, USA.
  • Attal M; Hematology, Institut Universitaire du Cancer Toulouse Oncopole, Toulouse, France.
  • Richardson PG; Hematologic Oncology, Dana-Farber Cancer Institute, Boston, USA.
  • Badros A; School of Medicine, University of Maryland, Baltimore, USA.
  • Hou J; Department of Hematology, Myeloma and Lymphoma Center, Changzheng Hospital, The Second Military Medical University, Shanghai, China.
  • Comenzo R; Hematology/Oncology, Tufts Medical Center, Boston.
  • Du J; Department of Hematology, Myeloma and Lymphoma Center, Changzheng Hospital, The Second Military Medical University, Shanghai, China.
  • Durie BGM; Samuel Oschin Cancer Center, Cedars-Sinai Medical Center, Los Angeles, USA.
  • San Miguel J; Navarra University Clinic, CIMA, Pamplona, Spain.
  • Einsele H; Internal Medicine II, University Hospital Wuerzburg, Wuerzburg, Germany.
  • Chen WM; Beijing Chaoyang Hospital, Capital Medical University, Beijing, China.
  • Garderet L; Hematology Clinic, Hôpital Saint Antoine, Paris, France.
  • Pietrantuono G; Unit of Hematology and Stem Cell Transplantation, IRCCS-CROB, Referral Cancer Center of Basilicata, Rionero in Vulture, Italy.
  • Hillengass J; Department of Hematology and Oncology, University of Heidelberg and German Cancer Research Center, Heidelberg, Germany.
  • Kyle RA; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, USA.
  • Moreau P; Hematology, University Hospital, Nantes, France.
  • Lahuerta JJ; Spanish Myeloma Group, Hospital Universitario 12 de Octubre, Madrid, Spain.
  • Landgren O; Hematologic Oncology, Memorial Sloan Kettering Cancer Center, New York, USA.
  • Ludwig H; 1st Medical Department and Oncology, Wilhelminenspital Der Stat Wien, Vienna, Austria.
  • Larocca A; Division of Hematology, University of Torino, Azienda Ospedaliero-Universitaria Città della Salute e della Scienza di Torino, Torino, Italy.
  • Mahindra A; School of Medicine, University of California, San Francisco, USA.
  • Cavo M; Department of Specialized, Experimental, & Diagnostic Medicine, University of Bolgona, Bologna, Italy.
  • Mazumder A; Medical Oncology, NYU Comprehensive Cancer Center, New York.
  • McCarthy PL; Department of Medicine, Roswell Park Cancer Center, Buffalo, USA.
  • Nouel A; Department of Hematology, Hospital Universitario Rutz y Paez, Bolivar, Venezuela.
  • Rajkumar SV; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, USA.
  • Reiman A; Department of Oncology, Saint John Regional Hospital, Saint John, New Brunswick, Canada.
  • Riva E; Hematology Department, Hospital de Clinicas, Montevideo, Uruguay.
  • Sezer O; Hematology Department, Memorial Hospital, Istanbul, Turkey.
  • Terpos E; School of Medicine, National and Kapodistrian University of Athens, Athens, Greece.
  • Turesson I; Department of Hematology and Coagulation Disorders, Skane University Hospital, Malmo, Sweden.
  • Usmani S; Levine Cancer Institute, Carolinas Healthcare System, Charlotte.
  • Weiss BM; Abramson Cancer Center, University of Pennsylvania, Philadelphia, USA.
  • Palumbo A; Division of Hematology, University of Torino, Azienda Ospedaliero-Universitaria Città della Salute e della Scienza di Torino, Torino, Italy.
Ann Oncol ; 28(2): 228-245, 2017 02 01.
Article em En | MEDLINE | ID: mdl-27864218
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Segunda Neoplasia Primária / Mieloma Múltiplo Tipo de estudo: Etiology_studies / Guideline / Incidence_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Ann Oncol Assunto da revista: NEOPLASIAS Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Itália País de publicação: Reino Unido
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Segunda Neoplasia Primária / Mieloma Múltiplo Tipo de estudo: Etiology_studies / Guideline / Incidence_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Ann Oncol Assunto da revista: NEOPLASIAS Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Itália País de publicação: Reino Unido